Top compounds associated with response to CCNE2


Feature Type Standardized
Nominal ANOVA
mRNA KPT185 CTRPv2 pan-cancer AAC 0.15 8e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 8e-05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 8e-05
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 9e-05
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.13 9e-05
mRNA I-BET-762 GDSC1000 pan-cancer AAC 0.11 0.0001
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA GMX-1778 CTRPv2 pan-cancer AAC 0.14 0.0001
Download CSV